États-Unis · Plateformes & données · MarketBeat

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

Publié par MarketBeat · États-Unis il y a 1 h

Cybin (NASDAQ:HELP) outlined plans for two late-stage mental health programs, with top-line data from its Phase III APPROACH study of HLP003 in major depressive disorder expected…

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

À lire aussi

Westinghouse Air Brake Technologies: 3 Key Takeaways for Long-Term Investors

Kazia gains as Guggenheim is latest to initiate at Buy on lead asset

Medicare is a bargain. What America can’t afford is private health insurance.

Initial jobless claims highlight Thursday’s economic calendar

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Cybin Eyes Q4 Phase III Depression Data as Anxiety Program Advances

Partager

À lire aussi

Westinghouse Air Brake Technologies: 3 Key Takeaways for Long-Term Investors

Kazia gains as Guggenheim is latest to initiate at Buy on lead asset

Medicare is a bargain. What America can’t afford is private health insurance.

Initial jobless claims highlight Thursday’s economic calendar

Goldman Sachs, JPMorgan and Morgan Stanley are dominating the AI stock boom. Here's their edge

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030